Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms of drug resistance in acute myeloid leukemia

1 Mar 2019

Abstract excerpt

Acute myeloid leukemia (AML) is a kind of malignant hematopoietic system disease characterized by abnormal proliferation, poor cell differentiation, and infiltration of bone marrow, peripheral blood, or other tissues. To date, the first-line treatment of AML is still based on daunorubicin and cytosine arabinoside or idarubicin and cytosine arabinoside regimen. However, the complete remission rate of AML is still...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30881045
DOI: 10.2147/ott.s191621

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanisms of drug resistance in acute myeloid leukemiaPMID 30881045Read ↗

Mechanisms, treatment strategies and predictive biomarkers of drug resistance in acute myeloid leukemia.Semantic proximity Read ↗

Mechanisms responsible for therapy resistance of acute myelogenous leukemia (AML).Semantic proximity Read ↗

The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML.Semantic proximity Read ↗

Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.Semantic proximity Read ↗

Research progress on gene mutations and drug resistance in leukemia.Semantic proximity Read ↗

Long non‐coding RNAs regulate treatment outcome in leukemia: What have we learnt recently?Semantic proximity Read ↗

Mechanisms of drug resistance in AML.Semantic proximity Read ↗

Mechanisms of Resistance to Small Molecules in Acute Myeloid LeukemiaSemantic proximity Read ↗

A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid LeukemiaSemantic proximity Read ↗

The Different Mechanisms of Cancer Drug Resistance: A Brief ReviewSemantic proximity Read ↗

Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?Semantic proximity Read ↗

Drug Resistance in Hematological MalignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.